This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.

Today's Headlines RSS

REGULATORY

MOF Official Unami Urges Full-Scale NHI Price Revision upon Next Sales Tax Hike

Hirotaka Unami, a new Ministry of Finance (MOF) budget examiner in charge of health affairs, called for conducting an extra market price survey and full-scale NHI drug price revision if ... > Read full story
BUSINESS
Eisai Books 18.7 Billion Yen in Payments to Medical Institutions in FY2013 (Sep.02)
BUSINESS
Astellas’ FY2013 Funding to Medical Institutions Totals 18.7 Billion Yen (Sep.02)
BUSINESS
33.2 Billion Yen Paid to Medical Institutions in FY2013: Daiichi Sankyo (Sep.02)
BUSINESS
Takeda’s Payments to Health Professionals Down 30% in FY2013 (Sep.02)
REGULATORY
METI to Request 20% Increase in Budget for Promotion of Science and Technology: FY2015 Budget Request (Sep.02)
> More Latest News

Photosmore

  
Sanofi Greater China Head Baschiera to Shepherd Japan Unit (Aug.29)Nippon Shinyaku Sets FY2018 Sales Target of 110 Billion Yen, Plans to Focus on Specialty Fields (Aug.28)MTPC Aims at Over 17% Share for SGLT-2 Inhibitor Canaglu in Japan: Sales Division Head (Aug.28)
  
Otsuka Holdings Takes Aim at 915 Billion Yen Pharma Sales in FY2018 after Abilify Patent Loss (Aug.27)CDISC CEO Advises Drug Makers to Collect Data Based on CDASH (Aug.27)Kyoto University, Astellas Aim to Develop Immunological Disease Cures, 11 Target Molecules Now under Screening (Aug.21)

News Categories

REGULATORY
   MOF Official Unami Urges Full-Scale NHI Price Revision upon Next Sales Tax Hike(Sep.02)
   METI to Request 20% Increase in Budget for Promotion of Science and Technology: FY2015 Budget Request(Sep.02)
   MHLW to Reinforce Follow-Up Surveys on HPV Vaccine Recipients(Sep.01)
BUSINESS
   Eisai Books 18.7 Billion Yen in Payments to Medical Institutions in FY2013(Sep.02)
   Astellas’ FY2013 Funding to Medical Institutions Totals 18.7 Billion Yen(Sep.02)
   33.2 Billion Yen Paid to Medical Institutions in FY2013: Daiichi Sankyo(Sep.02)
ORGANIZATION
   CDISC CEO Advises Drug Makers to Collect Data Based on CDASH(Aug.27)
   NEDO, NCC, Toray to Jointly Develop Simple Test Systems for Cancers and Dementia(Aug.20)
   Fair Discussions Necessary for Full Introduction of New Drug Development Premium: Chuikyo Member(Aug.12)
ACADEMIA
   Kyoto University, Astellas Aim to Develop Immunological Disease Cures, 11 Target Molecules Now under Screening(Aug.21)
   Chiba Univ. Once Again Advises Authors to Withdraw Papers from VART Study(Aug.19)
   Japanese Circulation Society Issues Warning Letter to Dr Matsubara and Co-Authors in Connection with Diovan Scandal(Aug.15)

Commentary

With No Pilot at Helm, Pharma Industry Embroiled in Confusion with Voluntary Funding Disclosures

Lexicon

Drug requiring guidance:
要指導医薬品

The Column

Is Your Body Language Louder than Your Speech?

Archives

Kyowa Kirin Initiates PIIb Study of Regpara Successor in Japan(Sep.02)
Kyowa Kirin Merges Ethics Office into CSR Promotion Dept., Following Improper Involvement of Its Employees in Clinical Study(Sep.02)
10-Year Epidemiology Study Finds No Significant Increase in Bladder Cancer Risk from Actos: Takeda(Sep.01)
Novartis Pharma Submits Improvement Plan, Notifies of Over 2,500 Unreported Serious ADRs(Sep.01)
Mundipharma Begins PII Trial on Antifolate Pralatrexate in Japan(Sep.01)

Most Read

1.
Sanofi Greater ...
2.
Pfizer Japan to...
3.
Nippon Shinyaku...
4.
MHLW Notifies H...
5.
Editor’s Pick: ...

News Calendar